September 13 Product: Roches Ocrevus Zunovo Indication: Multiple sclerosis People with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) have a new treatment option after the FDA greenlit Roches Ocrevus Zunovo Friday
It is vital to detoxify the body, support metabolism, make new DNA, and protect the body from oxidative stress
As dental professionals, physicians, and wellness practitioners expand their scope into integrative health, understanding the science behind peptides can help us better educate patients and make informed decisions about adjunctive therapies
however, these cells have a limited growth capacity and tend to lose their phenotype over time (Table 3)
Journal of Investigative Dermatology, 130(Suppl 1), S45